Dec 3 2013
MiniVax, Inc. (MiniVax) participated in the New Orleans BioInnovation Center's (NOBIC) second annual BioChallenge, a business competition part of the three-day Innovation Louisiana 2013 conference. MiniVax and three other companies were selected out of 19 companies to pitch at the event. The four companies presented their business plans to a panel of judges comprised of industry and investment experts. William Heim, Director of Operations, presented the scientific background, development plans, and business case for MiniVax. After the pitches were complete, MiniVax was declared winner and received the prize of $20,000 consisting of cash, legal services, donated office space, and consulting services.
Martin Preuveneers and Sue Preston, Co-Presidents of MiniVax, said, "We are delighted to have won this competition, which we feel is an endorsement of the work and plans we have put in place for MiniVax's lead program, a monoclonal antibody therapeutic against the fungal lung infection Pneumocystis pneumonia (PCP)."
Source: MiniVax, Inc.